A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Related Post

27 October, 2026

MASTERPLAN trial shows benefit from SBRT in pancreatic cancer

LATEST NEWS: 27 October 2026 Findings from the AGITG/TROG

21 October, 2026

Jess’s deeply personal reason for joining TROG’s Km’s for Cancer Research challenge

LATEST NEWS: 21 October 2026 For Jess Synge, taking